Related Experiment Video

Updated: Jun 22, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Management of diabetes in cardiac diseases]

Serhat Işik1, Tuncay Delibaşi, Dilek Berker

  • 1Ankara Numune Eğitim ve Araştirma Hastanesi, Endokrinoloji ve Metabolizma Hastaliklari Kliniği, Ankara, Türkiye. isik_serhat@yahoo.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|June 13, 2009
PubMed

Insights

Type 2 diabetes mellitus (DM) significantly increases cardiovascular disease (CVD) risk. Effective management requires addressing multiple risk factors beyond just glucose control for better patient outcomes.

Area of Science:

  • Endocrinology
  • Cardiology
  • Public Health

Context:

  • Type 2 diabetes mellitus (DM) is a global health concern with rising incidence.
  • Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in type 2 DM patients.
  • Diabetic patients face a worse prognosis compared to non-diabetics.

Purpose:

  • To highlight the critical link between type 2 DM and CVD.
  • To emphasize the role of co-existing risk factors in accelerating atherosclerosis.
  • To advocate for a comprehensive, multi-risk factor management approach in type 2 DM.

Summary:

  • Type 2 DM is associated with accelerated atherosclerosis and increased CVD risk, often exacerbated by hyperlipidemia, hypertension, and obesity.
  • These conditions, whether part of metabolic syndrome or not, contribute significantly to cardiovascular events in diabetic individuals.
  • Optimal management of type 2 DM necessitates a holistic strategy targeting multiple cardiovascular risk factors, not solely glycemic control.

Impact:

  • Improved understanding of CVD risk in type 2 DM.
  • Promotes a shift towards integrated care models for diabetic patients.
  • Potential to reduce cardiovascular morbidity and mortality in the diabetic population.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...